Advanced Therapy (ATMP)
The EU regulatory class covering gene, tissue and cell-based medicines.
Why Advanced Therapy (ATMP) matters when choosing treatment
A regulatory classification (EU ATMP, advanced therapy medicinal product) for cell and gene therapies that require proof of quality, safety, and efficacy before approval. It's a gold-standard designation meaning the therapy has undergone rigorous manufacturing oversight and clinical testing. Clinics advertising "advanced therapy" products are working within regulated frameworks; clinics bypassing this classification are often operating in regulatory grey zones. Ask clinics whether their products hold ATMP designation or equivalent (FDA approval, etc.); if not, ask why and whether they're pursuing it. Lack of regulatory approval signals either early-stage research or intentional circumvention.